SCHEMBL28277232

SCHEMBL28277232

Cc1nc2ccc(-c3ccncc3)cc2c(N)c1C

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAP4K4 O95819 3/20 0.50
PIK3CA P42336 5/20 0.46
PIK3CD O00329 2/20 0.46
PIK3CB P42338 2/20 0.46
PIK3CG P48736 2/20 0.46
PIP5K1C O60331 1/20 0.46
PI4KA P42356 1/20 0.46
PI4KB Q9UBF8 1/20 0.46
JAK2 O60674 1/20 0.44
AAK1 Q2M2I8 7/20 0.43
CHEK1 O14757 1/20 0.41
GSK3B P49841 1/20 0.41
MKNK1 Q9BUB5 1/20 0.41
BMP2K Q9NSY1 1/20 0.41
PDPK1 O15530 2/20 0.41
CDK8 P49336 1/20 0.40
CLK2 P49760 1/20 0.40
CDK7 P50613 1/20 0.40
CDK9 P50750 1/20 0.40
CDK5 Q00535 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1857081 0.75 ACHE (0.49) KDM4EMEN1ALDH1A1LMNAMAPT
SCHEMBL4353977 0.72 MAP4K4 (0.48) MAP4K4PIK3CAPIK3CDPIK3CBPIK3CG
SCHEMBL29023207 0.72 ACHE (0.65) CDK9
SCHEMBL30398246 0.72 ACHE (0.65) CDK9
SCHEMBL16974250 0.71 PDGFRB (0.49) MAP4K4PIK3CAPIK3CDPIK3CBPIK3CG
SCHEMBL19219068 0.71 MAPT (0.47) KDM4EMEN1ALDH1A1LMNAMAPT
SCHEMBL16974229 0.71 PIK3CA (0.44) MAP4K4PIK3CAPIK3CDPIK3CBPIK3CG
SCHEMBL3332604 0.71 AAK1 (0.44) MAP4K4PIK3CAPIK3CDPIK3CBPIK3CG
Ammonia Solution, Strong SCHEMBL28083832 0.70 DYRK1A (0.49) MAP4K4PIK3CAPIK3CDPIK3CBPIK3CG
SCHEMBL12575926 0.70 HSP90AB1 (0.55) PIK3CADYRK1AKDM4EMEN1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-106132951-B quinoline-based kinase inhibitors 百时美施贵宝公司 2019-02-12 CN claimed
CN-106132951-B quinoline-based kinase inhibitors 百时美施贵宝公司 2019-02-12 CN disclosed